These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38170084)

  • 21. Equipment and Analytical Companies Meeting Continuous Challenges May 20-21 2014 Continuous Manufacturing Symposium.
    Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):821-831. PubMed ID: 28756844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. System-wide hybrid MPC-PID control of a continuous pharmaceutical tablet manufacturing process via direct compaction.
    Singh R; Ierapetritou M; Ramachandran R
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1164-82. PubMed ID: 23523542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intelligent co-design of material, process, and equipment for manufacturing high-quality traditional Chinese medicine preparations].
    Xu B; Qiao YJ; DU SY; Zhang ZQ; Xiao W
    Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(15):3977-3987. PubMed ID: 37802765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic engineering: the ultimate paradigm for continuous pharmaceutical manufacturing.
    Yadav VG; Stephanopoulos G
    ChemSusChem; 2014 Jul; 7(7):1847-53. PubMed ID: 24719301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toward Higher QA: From Parametric Release of Sterile Parenteral Products to PAT for Other Pharmaceutical Dosage Forms.
    Hock SC; Constance NX; Wah CL
    PDA J Pharm Sci Technol; 2012; 66(4):371-91. PubMed ID: 22767885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using Residence Time Distributions (RTDs) to Address the Traceability of Raw Materials in Continuous Pharmaceutical Manufacturing.
    Engisch W; Muzzio F
    J Pharm Innov; 2016; 11():64-81. PubMed ID: 26937258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Raw material variability of an active pharmaceutical ingredient and its relevance for processability in secondary continuous pharmaceutical manufacturing.
    Stauffer F; Vanhoorne V; Pilcer G; Chavez PF; Rome S; Schubert MA; Aerts L; De Beer T
    Eur J Pharm Biopharm; 2018 Jun; 127():92-103. PubMed ID: 29452241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An integrated data management and informatics framework for continuous drug product manufacturing processes: A case study on two pilot plants.
    Chen Y; Sampat C; Huang YS; Ganesh S; Singh R; Ramachandran R; Reklaitis GV; Ierapetritou M
    Int J Pharm; 2023 Jul; 642():123086. PubMed ID: 37257793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conceptual design of distillation-based hybrid separation processes.
    Skiborowski M; Harwardt A; Marquardt W
    Annu Rev Chem Biomol Eng; 2013; 4():45-68. PubMed ID: 23394170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Methodology and application of process analytical technology (PAT) for traditional Chinese medicine manufacturing:a review].
    Xiong HS; Zhang Q; Zhang SN; Cai JY; Su J; Zhu YH; Yan KJ
    Zhongguo Zhong Yao Za Zhi; 2023 Jan; 48(1):22-29. PubMed ID: 36725254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of critical process parameters and critical material attributes on the critical quality attributes of liposomal formulations prepared using continuous processing.
    Yenduri G; Costa AP; Xu X; Burgess DJ
    Int J Pharm; 2022 May; 619():121700. PubMed ID: 35358645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small-Scale Continuous Drug Product Manufacturing using Dropwise Additive Manufacturing and Three Phase Settling for Integration with Upstream Drug Substance Production.
    Sundarkumar V; Nagy ZK; Reklaitis GV
    J Pharm Sci; 2022 Aug; 111(8):2330-2340. PubMed ID: 35341723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Achieving continuous manufacturing: technologies and approaches for synthesis, workup, and isolation of drug substance. May 20-21, 2014 Continuous Manufacturing Symposium.
    Baxendale IR; Braatz RD; Hodnett BK; Jensen KF; Johnson MD; Sharratt P; Sherlock JP; Florence AJ
    J Pharm Sci; 2015 Mar; 104(3):781-91. PubMed ID: 25470351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Current status, trends, and challenges of continuous manufacturing technology for oral traditional Chinese medicine solid preparations].
    Wang ZQ; Wang XC; Zhong ZJ; Liu ZF; Wang YQ; Yi B; Yang M; Zhu WF; Wu ZF
    Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(16):4536-4544. PubMed ID: 37802880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PAT-based batch statistical process control of a manufacturing process for a pharmaceutical ointment.
    Bostijn N; Dhondt W; Vervaet C; De Beer T
    Eur J Pharm Sci; 2019 Aug; 136():104946. PubMed ID: 31170525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Life cycle analysis within pharmaceutical process optimization and intensification: case study of active pharmaceutical ingredient production.
    Ott D; Kralisch D; Denčić I; Hessel V; Laribi Y; Perrichon PD; Berguerand C; Kiwi-Minsker L; Loeb P
    ChemSusChem; 2014 Dec; 7(12):3521-33. PubMed ID: 25251078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous manufacturing of a pharmaceutical cream: Investigating continuous powder dispersing and residence time distribution (RTD).
    Bostijn N; Van Renterghem J; Vanbillemont B; Dhondt W; Vervaet C; De Beer T
    Eur J Pharm Sci; 2019 Apr; 132():106-117. PubMed ID: 30831193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated Continuous Wet Granulation and Drying: Process Evaluation and Comparison with Batch Processing.
    Forster SP; Dippold E; Haser A; Emanuele D; Meier R
    Pharmaceutics; 2023 Sep; 15(9):. PubMed ID: 37765286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design of condition-based maintenance framework for process operations management in pharmaceutical continuous manufacturing.
    Ganesh S; Su Q; Vo LBD; Pepka N; Rentz B; Vann L; Yazdanpanah N; O'Connor T; Nagy ZK; Reklaitis GV
    Int J Pharm; 2020 Sep; 587():119621. PubMed ID: 32663581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent Developments and Challenges in Optimization-Based Process Synthesis.
    Chen Q; Grossmann IE
    Annu Rev Chem Biomol Eng; 2017 Jun; 8():249-283. PubMed ID: 28375774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.